Product Introduction:
Path 30 Tablet is a calcimimetic agent containing Cinacalcet 30 mg. It works by increasing the sensitivity of calcium-sensing receptors on the parathyroid gland, leading to reduced parathyroid hormone (PTH) levels, and ultimately lowering blood calcium levels. It is primarily used in CKD patients on dialysis who suffer from secondary hyperparathyroidism.
Uses:
-
Secondary hyperparathyroidism in chronic kidney disease (on dialysis)
-
Parathyroid carcinoma
-
Primary hyperparathyroidism (when surgery is not an option)
Benefits:
-
Reduces elevated parathyroid hormone (PTH) levels
-
Lowers serum calcium and phosphate levels
-
Helps prevent bone and cardiovascular complications in CKD
-
Non-surgical treatment option for hyperparathyroidism
Composition (per tablet):
-
Cinacalcet Hydrochloride 30 mg
Side Effects:
Common side effects may include:
-
Nausea
-
Vomiting
-
Muscle pain
-
Low blood calcium (hypocalcemia)
-
Dizziness
Serious but rare:
-
Seizures (due to hypocalcemia)
-
Allergic reactions
-
Worsening of heart rhythm disturbances
Safety Advice:
-
Take with food or shortly after a meal to improve absorption
-
Regular monitoring of serum calcium, phosphorus, and PTH is essential
-
Not recommended in patients with hypocalcemia
-
Use with caution in patients with seizures or cardiac arrhythmias
-
Inform your doctor about any other ongoing medications
-
Store at room temperature, away from moisture and sunlight
-
Keep out of reach of children
